Akèy › Leksemi mieloïd egi › New York › The Bronx
Etid klinik pou Leksemi mieloïd egi nan The Bronx, NY
15 etid pou Leksemi mieloïd egi ap chèche patisipan nan sit nan ak bò kote The Bronx (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Ap rekriteFaz 2
- Montefiore Medical Center - Moses Campus, The Bronx
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
Ap rekriteFaz 2/3
- Montefiore Medical Center - Moses Campus /ID# 279399, The Bronx
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
- Montefiore Medical Center - Moses Campus, The Bronx
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Ap rekriteFaz 3
- Einstein-Montefiore Medical Center, The Bronx
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
- Montefiore Medical Center - Moses Campus, The Bronx
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Ap rekriteFaz 3
- Montefiore Medical Center - Moses Campus, The Bronx
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
Ap rekriteFaz 3
- Montefiore Medical Center - Moses Campus, The Bronx
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Ap rekriteFaz 1/2
- Montefiore Medical Center - Moses Campus, The Bronx
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Ap rekriteEtid obsèvasyon
- Children's Hospital at Montefiore, The Bronx
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
Ap rekriteFaz 1
- Montefiore Medical Center, The Bronx
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Ap rekriteFaz 2/3
- Montefiore Medical Center, The Bronx
FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia
Ap rekriteFaz 1
- Montefiore Medical Center, The Bronx
Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS
Ap rekriteFaz 1
- Montefiore Einstein Cancer Center and Children's Hospital at Montefiore (CHAM), The Bronx
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
Ap rekriteFaz 2
- Montefiore Medical Center, The Bronx
Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML
Ap rekriteFaz 1Volontè an sante akeyi
- Montefiore Medical Center, The Bronx
Etid Leksemi mieloïd egi nan lòt vil
- Houston, TX85 etid
- New York City, NY51 etid
- Boston, MA44 etid
- Seattle, WA41 etid
- Baldwin Park, CA40 etid
- Columbus, OH35 etid
- Philadelphia, PA34 etid
- Durham, NC33 etid
- Atlanta, GA31 etid
- Tampa, FL29 etid
- Chicago, IL26 etid
- Portland, OR25 etid
Lòt etid nan The Bronx
- Kansè Poumon ki pa ti selil25 etid
- Kansè nan tete17 etid
- Kansè poumon13 etid
- Kansè (tout kalite)12 etid
- Maladi kadyovaskilè12 etid
- Ensifizyans kadyak11 etid
- Kansè pwostat11 etid
- Kansè Metastatik9 etid
- Kansè kolorektal9 etid
- Karsinòm selil skuamèz tèt ak kou9 etid
- Sendwòm myelodisplastik9 etid
- Asm9 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.